Megan E. Miller, Ph.D.
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Google:
"Megan Miller"Mean distance: 19.15 (cluster 11)
Parents
Sign in to add mentorKay Lund | grad student | 2002 | UNC Chapel Hill | |
(The role of suppressors of cytokine signaling in the actions of growth hormone on the intestine during parenteral nutrition.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fruchtman S, Simmons JG, Michaylira CZ, et al. (2005) Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 289: G342-50 |
Miller ME, Michaylira CZ, Simmons JG, et al. (2004) Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology. 127: 570-81 |
Dahly EM, Miller ME, Lund PK, et al. (2004) Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats. The Journal of Nutrition. 134: 530-7 |
Greenhalgh CJ, Miller ME, Hilton DJ, et al. (2002) Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease. Gastroenterology. 123: 2064-81 |
Miller M, Simmons J, Ney D, et al. (2001) Suppressor of cytokine signaling-2 (SOCS-2) may limit GH-induced intestinal mucosal collagen synthesis Gastroenterology. 120 |
Miller ME, Goebel HN, Williams KL, et al. (2000) Suppressor of cytokine signaling-3 (SOCS-3) mRNA is preferentially induced during experimental enterocolitis, ulcerative colitis and Crohn's disease Regulatory Peptides. 94: 67 |
Williams KL, Miller ME, DaCosta CM, et al. (2000) Evidence for inhibition of cytokine action by growth hormone during recovery from experimental enterocolitis Regulatory Peptides. 94: 20 |